Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfizer Inc (NYSE:PFE)

33.70
Delayed Data
As of 4:00pm ET
 +0.90 / +2.74%
Today’s Change
28.25
Today|||52-Week Range
36.46
+4.40%
Year-to-Date
9 Figures That Sum Up Pfizer, Inc.'s First Quarter
6:23pm / MotleyFool.com
What to Look For When Pfizer (PFE) Posts Q1 Results
Apr 29 / TheStreet.com
Congress Not Likely to Make a Substantive Move in the Tax Space
5:03pm / TheStreet.com
3 Drug Stocks Reporting Early Next Week: PFE, MYL, MNK
Apr 29 / Zacks.com
Pfizer's Strong Results Driven by Older Products
1:47pm / TheStreet.com
Sanofi First Quarter Shows Why it Wants but Doesn't Need Medivation
Apr 29 / TheStreet.com
Trending Tickers: YELP, AIG, GM, F
1:35pm / TheStreet.com
Bristol-Myers (BMY) Tops Q1 Earnings, Updates 2016 View
Apr 28 / Zacks.com
3 Stocks Improving Performance Of The Drugs Industry
1:15pm / TheStreet.com
Pfizer (PFE) to Report Q1 Earnings: Will the Stock Surprise?
Apr 28 / Zacks.com
Key Healthcare Earnings for May 3: CVS, MYL, PFE
12:38pm / Zacks.com
UnitedHealths Obamacare Changes to Affect Healthcare Sector
Apr 27 / GuruFocus News
Stocks Under Pressure on Global Growth Woes
11:55am / TheStreet.com
Daniel Loeb warns of hedge fund 'killing field'
Apr 27 / FT.com
Pfizer's (PFE) Stock Gains in Pre-Market on Q1 Earnings Beat
9:53am / Zacks.com
Tax Inversions: Explaining What They Are, How We Got Here and What's Next
Apr 26 / TheStreet.com
Stocks Extend Losses as China Sparks Growth Worries
9:42am / TheStreet.com
Will the Next President Be as Tough on Mergers and Acquisitions as Obama?
Apr 26 / TheStreet.com
Pfizer (PFE) Stock Climbs on Strong Q1 Earnings, Higher Guidance
8:59am / TheStreet.com
Treasury Department Was 'Targeting' Pfizer-Allergan Deal
Apr 26 / TheStreet.com
Pfizer (PFE) Beats on Q1 Earnings and Revenues
8:52am / Zacks.com
With New Treasury Department Rules, Is This the End of Tax Inversion Deals?
Apr 26 / TheStreet.com
Pfizer (PFE) Rising Before The Market Opens
7:59am / TheStreet.com
Healthcare Q1 Earnings Look Solid: ETFs to Benefit
Apr 25 / Zacks.com
Stock Futures Slide on Global Economy Health Worries
7:44am / TheStreet.com
Vaccine development needs global alliance
Apr 24 / FT.com
"Unexpected" Australian Rate Cut To Record Low Unleashes FX Havoc, Global "Risk Off"
6:57am / Investing Channel
Vaccines are among big pharma's best-selling products
Apr 24 / FT.com
May 3 Premarket Briefing: 10 Things You Should Know
6:04am / TheStreet.com
3 Stocks We're Ready to Buy Again
Apr 22 / MotleyFool.com
Stocks: 5 things to know before the open
5:28am / CNNMoney.com
Better Buy: Pfizer Inc. vs. AbbVie
Apr 21 / MotleyFool.com
Dollar hits 15-month low as yen surges
3:44am / FT.com
Pfizer Reports Positive Data on Breast Cancer Drug Ibrance
Apr 20 / Zacks.com
What's Ahead Tuesday: Will Etsy Deliver on Revenue Growth?
May 02 / TheStreet.com
3 Value Stocks Near 52-Week Lows Worth Buying
Apr 20 / MotleyFool.com
Martin Shkreli is heading back to court
May 02 / CNNMoney.com
Johnson & Johnson Boosts Guidance on Strong 1st-Quarter Results
Apr 19 / MotleyFool.com
The Zacks Analyst Blog Highlights: Amgen, Johnson & Johnson, Pfizer, Mylan and Mallin...
May 02 / Zacks.com
Paulson's funds plunge nearly $2bn on Allergan and Valeant bets
Apr 19 / FT.com
7 Things on Investors' Minds Heading Into Pfizer's Q1 Report Tomorrow
May 02 / MotleyFool.com
Top 50 U.S. companies hold $1.4 trillion in cash offshore
Apr 14 / CNNMoney.com
Slew Of Negative News, Defaults And Failed Mergers Push Futures In The Green
May 02 / Investing Channel
Companies cannot escape nationalities and borders
Apr 13 / FT.com
Investors wary despite US earnings beating forecasts
May 01 / FT.com
M&A splurge comes home to roost
Apr 08 / FT.com
Concordia raises NHS eye drug price 14-fold
May 01 / FT.com
M&A deals worth $370bn torpedoed by Obama administration
Apr 07 / FT.com
3 Big Merger Deals That Regulators Challenged and What It Means
Apr 30 / TheStreet.com
Pfizer chief's long quest for tax inversion ends in failure
Apr 06 / FT.com